Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 8:20 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 409–432 of 667 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: University of Illinois Chicago Clear all

Conditions: Respiratory Distress, Acute Lung Injury
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Hot Flushes, Hot Flashes
Interventions: Bupivicaine, Saline; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 30 Years to 70 Years · Female only
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: ESRD
Interventions: Patient-Centered Medical Home for Kidney Disease (PCMH-KD); Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Acute Pancreatitis
Interventions: Not listed
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2030
U.S. locations: 13
States / cities: Los Angeles, California • Stanford, California • Gainesville, Florida + 8 more

Conditions: Opioid-use Disorder
Interventions: Telemedicine Linkage Intervention; Behavioral
Lead sponsor: Chestnut Health Systems; Other
Eligibility: 18 Years and older
Enrollment: 275 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Type 1 Diabetes (T1D)
Interventions: Sleep stability intervention; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 50 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Thromboembolism, Blood Coagulation Disorders, Cardiovascular Disease, Vascular Disease
Interventions: Patient Self-Monitoring vs Anticoagulation Clinic; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 21 Years and older
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Asthma
Interventions: Group A - Patient Education, Group B - Patient Education with Nutrition Counseling; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 323 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Head Neck Cancer, Intratumoral Injection
Interventions: RiMO-301; Drug
Lead sponsor: Coordination Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Kidney Diseases
Interventions: Control, Protein, Protein + Exercise; Dietary Supplement · Behavioral
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 30 Years to 80 Years
Enrollment: 138 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2018
U.S. locations: 2
States / cities: Chicago, Illinois • Urbana, Illinois

Conditions: Intracerebral Hemorrhage, ICH - Intracerebral Hemorrhage
Interventions: Minimally Invasive surgery (MIS), Deferoxamine, Standard Medical Care (SMD); Procedure · Drug · Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 80 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Stroke
Interventions: Virtual-reality based dance training; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 90 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Cognitive Function 1, Social
Interventions: BAILAMOS dance program plus MIND diet, BAILAMOS dance program plus Health Education; Behavioral
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 50 Years and older
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Chronic Pain, Sickle Cell Disease, Sleep Disturbance
Interventions: Mobile bindfulness-based intervention; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 15 Years to 39 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Acute Myeloid Leukemia
Interventions: Cytarabine, Idarubicin, Omacetaxine mepesuccinate; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 70 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Head and Neck Cancer
Interventions: Isocaloric and iso-nitrogenous standard enteral tube feeds, Nestle IMPACT AR; Dietary Supplement
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Sickle Cell, Sickle Cell Disease, Sickle Cell Disease Without Crisis, Mediterranean Diet
Interventions: Mediterranean Diet, Usual Diet; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Drug/Agent Toxicity by Tissue/Organ, Head and Neck Cancer, Radiation Toxicity
Interventions: amifostine trihydrate, cisplatin, paclitaxel, radiation therapy; Drug · Radiation
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1997
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Mental Disorder
Interventions: Building Financial Wellness, Services as Usual; Behavioral · Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Heart Failure, Dilated Cardiomyopathy (DCM)
Interventions: Not listed
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2038
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Overweight and Obesity
Interventions: Not listed
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 60 Years
Enrollment: 139 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Gastric Adenocarcinoma, Gastric Cancer
Interventions: Neoadjuvant chemotherapy, Olanzapine; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Fall Prevention
Interventions: Task-Specific Balance Training, Treadmill Perturbation Training, Conventional Balance Training; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 60 Years to 90 Years
Enrollment: 315 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Circumcision, Male, HIV, AIDS
Interventions: Voluntary medical male circumcision; Procedure
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 40 Years · Male only
Enrollment: 539 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

Lung Injury Prediction Study

Stellate Ganglion Block (SGB) For Women for Breast Cancer

Bringing Care to Patients: Patient-Centered Medical Home for Kidney Disease

Diabetes RElated to Acute Pancreatitis and Its Mechanisms

Project STAMINA (Syringe Service Telemedicine Access for Medication-assisted Intervention Through NAvigation)

Circadian Mechanisms, Glucose, and CV Risks in T1D

Patient-Centered Anticoagulation Self-Monitoring in Minority Patients

Addressing Quality of Life, Clinical Outcomes, and Mechanisms in Uncontrolled Asthma Following the DASH Dietary Pattern

Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer

Intra Hemodialytic Oral Protein and Exercise (IHOPE)

Synergistic Minimally Invasive Surgery and Deferoxamine in ICH

Alternative Therapies for Improving Physical Function in Individuals With Stroke

Optimizing Cognition Via Exercise and Nutrition

Mindfulness-Based Intervention for Pain and Sleep in Adolescents and Young Adults With Sickle Cell Disease

AML-02: Omacetaxine With Standard-of-Care Induction With Cytarabine & Idarubicin in Newly-Diagnosed AML Patients

Perioperative Nutritional Optimization in Head and Neck Cancer Patients

Sickle Cell, Pain and Mediterranean Diet

Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer

Building Financial Wellness Randomized Controlled Trial

UIC Multi-Ethnic DCM Registry

Circadian Timing, Information Processing and Energy Balance Study

GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer

Aging and Task-specific Training to Reduce Falls

Male Circumcision Services for HIV Prevention in the Dominican Republic